Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.

[1]  N. Siseles,et al.  Higher values of hepatic lipase activity in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins , 2001, Menopause.

[2]  J. Hokanson,et al.  Common Hepatic Lipase Gene Promoter Variant Determines Clinical Response to Intensive Lipid-Lowering Treatment , 2000, Circulation.

[3]  B. Nordestgaard,et al.  Common Cholesteryl Ester Transfer Protein Mutations, Decreased HDL Cholesterol, and Possible Decreased Risk of Ischemic Heart Disease: The Copenhagen City Heart Study , 2000, Circulation.

[4]  G. Jensen,et al.  Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene. , 2000, Circulation.

[5]  R. Frikke-Schmidt,et al.  Apolipoprotein E genotype: epsilon32 women are protected while epsilon43 and epsilon44 men are susceptible to ischemic heart disease: the Copenhagen City Heart Study. , 2000, Journal of the American College of Cardiology.

[6]  P. Wilson,et al.  Association of the C-514T polymorphism in the hepatic lipase gene with variations in lipoprotein subclass profiles: The Framingham Offspring Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[7]  J. Hokanson,et al.  A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[8]  K. Tan,et al.  Roles of hepatic lipase and cholesteryl ester transfer protein in determining low density lipoprotein subfraction distribution in Chinese patients with non-insulin-dependent diabetes mellitus. , 1999, Atherosclerosis.

[9]  S. Grundy,et al.  Hepatic lipase: new insights from genetic and metabolic studies. , 1999, Current opinion in lipidology.

[10]  J. Hokanson,et al.  Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. , 1999, Circulation.

[11]  P. Talmud,et al.  The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B : European Atherosclerosis Research Study (EARS) II. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[12]  J. Hokanson,et al.  Common variants in the promoter of the hepatic lipase gene are associated with lower levels of hepatic lipase activity, buoyant LDL, and higher HDL2 cholesterol. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[13]  C. Bouchard,et al.  Serum lipids, lipoproteins, and lipid metabolizing enzymes in identical twins discordant for obesity. , 1998, The Journal of clinical endocrinology and metabolism.

[14]  S. Grundy,et al.  The -514 polymorphism in the hepatic lipase gene (LIPC) does not influence androgen-mediated stimulation of hepatic lipase activity. , 1998, Journal of lipid research.

[15]  M. Taskinen,et al.  Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Invsestigators. , 1998, The Journal of clinical investigation.

[16]  S. Grundy,et al.  Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC). , 1998, Journal of lipid research.

[17]  J. Jukema,et al.  Common C-to-T substitution at position -480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[18]  L. Tiret,et al.  Hepatic lipase gene polymorphisms influence plasma HDL levels. Results from Finnish EARS participants. European Atherosclerosis Research Study. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[19]  S. Grundy,et al.  A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Yamashita,et al.  Molecular genetics of plasma cholesteryl ester transfer protein. , 1997, Current opinion in lipidology.

[21]  A. Tall,et al.  Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. , 1996, The Journal of clinical investigation.

[22]  Helen H. Hobbs,et al.  Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor , 1996, Science.

[23]  P. Barter,et al.  High-density lipoproteins and coronary heart disease. , 1991, Journal of cardiovascular risk.

[24]  S. Eisenberg,et al.  Triacylglycerol and phospholipid hydrolysis in human plasma lipoproteins: role of lipoprotein and hepatic lipase. , 1992, Biochemistry.

[25]  M. Austin.  Plasma triglyceride and coronary heart disease. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.